BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sato A, Matsubayashi K, Morishima T, Nakata K, Kawakami K, Miyashiro I. Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study. BMC Cancer 2021;21:264. [PMID: 33691661 DOI: 10.1186/s12885-021-08011-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sato A, Morishima T, Takeuchi M, Nakata K, Kawakami K, Miyashiro I. Survival in non-small cell lung cancer patients with versus without prior cancer. Sci Rep 2023;13:4269. [PMID: 36922574 DOI: 10.1038/s41598-023-30850-2] [Reference Citation Analysis]
2 Li D, Deng C, Fu F, Bai J, Li Y, Zhang Y, Chen H. Impact of Prior Cancer History on Outcomes of Resected Lung Cancer. Ann Surg Oncol 2023;30:1534-40. [PMID: 36635522 DOI: 10.1245/s10434-022-12597-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liu J, Wang H, Wang Z, Han W, Hong L. The Global, Regional, and National Uterine Cancer Burden Attributable to High BMI from 1990 to 2019: A Systematic Analysis of the Global Burden of Disease Study 2019. J Clin Med 2023;12. [PMID: 36902661 DOI: 10.3390/jcm12051874] [Reference Citation Analysis]
4 Sato A, Morishima T, Takeuchi M, Nakata K, Kawakami K, Miyashiro I. Survival in Non-Small Cell Lung Cancer Patients With Versus Without Prior Cancer: A Multicenter Retrospective Cohort Study.. [DOI: 10.21203/rs.3.rs-2011692/v1] [Reference Citation Analysis]
5 Khlanta DA, Gens GP. Management of patients with multiple primary сancer in the practice of a modern oncologist. Case report and literature review. Sib onkol ž 2022;21:147-155. [DOI: 10.21294/1814-4861-2022-21-4-147-155] [Reference Citation Analysis]
6 Montagut-Martínez P, Pérez-Cruzado D, Gutiérrez-Sánchez D. Cancer-related fatigue measures in palliative care: A psychometric systematic review. Eur J Cancer Care (Engl) 2022;:e13642. [PMID: 35822246 DOI: 10.1111/ecc.13642] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Masuda T, Fujitaka K, Suzuki T, Hamai K, Matsumoto N, Matsumura M, Isoyama S, Ueno S, Mito M, Yamaguchi K, Sakamoto S, Kawano R, Masuda K, Nishino R, Ishikawa N, Yamasaki M, Hattori N. Phase 2 study of first-line pembrolizumab monotherapy in elderly patients with non-small-cell lung cancer expressing high PD-L1. Thorac Cancer 2022. [PMID: 35488720 DOI: 10.1111/1759-7714.14428] [Reference Citation Analysis]
8 Li G, Zhang C, Wang C, Xiao L. Acupuncture against chronic postsurgical pain in non-small cell lung cancer patients: A protocol of randomized controlled trial. Medicine (Baltimore) 2021;100:e27461. [PMID: 34622872 DOI: 10.1097/MD.0000000000027461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Sun Z, Zhang J, Li J, Li M, Ge J, Wu P, You B, Qian H. Roles of Mesenchymal Stem Cell-Derived Exosomes in Cancer Development and Targeted Therapy. Stem Cells Int 2021;2021:9962194. [PMID: 34335792 DOI: 10.1155/2021/9962194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]